Iqbal J Hussain is General Counsel of Centessa Pharmaceuticals plc. Currently has a direct ownership of 105,386 shares of CNTA, which is worth approximately $1.68 Million. The most recent transaction as insider was on Jul 15, 2025, when has been sold 6,000 shares (Ordinary Shares) at a price of $14.93 per share, resulting in proceeds of $89,580. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 105K
0% 3M change
48.59% 12M change
Total Value Held $1.68 Million

IQBAL J HUSSAIN Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 15 2025
SELL
Open market or private sale
$89,580 $14.93 p/Share
6,000 Reduced 5.39%
105,386 Ordinary Shares
Jul 15 2025
BUY
Exercise of conversion of derivative security
$35,040 $5.84 p/Share
6,000 Added 5.11%
111,386 Ordinary Shares
Jun 24 2025
SELL
Open market or private sale
$168,240 $14.02 p/Share
12,000 Reduced 10.22%
105,386 Ordinary Shares
Jun 24 2025
BUY
Exercise of conversion of derivative security
$70,080 $5.84 p/Share
12,000 Added 9.27%
117,386 Ordinary Shares
May 01 2025
SELL
Open market or private sale
$4,354 $14.0 p/Share
311 Reduced 0.29%
105,386 Ordinary Shares
May 01 2025
BUY
Exercise of conversion of derivative security
$1,816 $5.84 p/Share
311 Added 0.29%
105,697 Ordinary Shares
Apr 28 2025
SELL
Open market or private sale
$29,140 $14.01 p/Share
2,080 Reduced 1.94%
105,386 Ordinary Shares
Apr 28 2025
BUY
Exercise of conversion of derivative security
$12,147 $5.84 p/Share
2,080 Added 1.9%
107,466 Ordinary Shares
Apr 25 2025
SELL
Open market or private sale
$50,526 $14.0 p/Share
3,609 Reduced 3.31%
105,386 Ordinary Shares
Apr 25 2025
BUY
Exercise of conversion of derivative security
$21,076 $5.84 p/Share
3,609 Added 3.21%
108,995 Ordinary Shares
Mar 17 2025
SELL
Open market or private sale
$98,700 $16.45 p/Share
6,000 Reduced 5.39%
105,386 Ordinary Shares
Mar 17 2025
BUY
Exercise of conversion of derivative security
$35,040 $5.84 p/Share
6,000 Added 5.11%
111,386 Ordinary Shares
Feb 18 2025
SELL
Open market or private sale
$98,880 $16.48 p/Share
6,000 Reduced 5.39%
105,386 Ordinary Shares
Feb 18 2025
BUY
Exercise of conversion of derivative security
$35,040 $5.84 p/Share
6,000 Added 5.11%
111,386 Ordinary Shares
Feb 01 2025
SELL
Payment of exercise price or tax liability
$217,912 $16.92 p/Share
12,879 Reduced 10.89%
105,386 Ordinary Shares
Jan 15 2025
SELL
Open market or private sale
$91,740 $15.29 p/Share
6,000 Reduced 4.83%
118,265 Ordinary Shares
Jan 15 2025
BUY
Exercise of conversion of derivative security
$35,040 $5.84 p/Share
6,000 Added 4.61%
124,265 Ordinary Shares
Dec 31 2024
SELL
Payment of exercise price or tax liability
$122,952 $16.35 p/Share
7,520 Reduced 5.98%
118,265 Ordinary Shares
Dec 16 2024
SELL
Open market or private sale
$1,273,584 $16.39 p/Share
77,705 Reduced 38.19%
125,785 Ordinary Shares
Dec 16 2024
BUY
Exercise of conversion of derivative security
$35,040 $5.84 p/Share
6,000 Added 2.86%
203,490 Ordinary Shares
Sep 30 2024
SELL
Payment of exercise price or tax liability
$118,740 $15.79 p/Share
7,520 Reduced 3.67%
197,490 Ordinary Shares
Jun 30 2024
SELL
Payment of exercise price or tax liability
$67,905 $9.03 p/Share
7,520 Reduced 3.54%
205,010 Ordinary Shares
Mar 31 2024
SELL
Payment of exercise price or tax liability
$84,976 $11.3 p/Share
7,520 Reduced 3.42%
212,530 Ordinary Shares
Feb 01 2024
SELL
Payment of exercise price or tax liability
$64,578 $8.19 p/Share
7,885 Reduced 3.46%
220,050 Ordinary Shares
Feb 01 2024
BUY
Grant, award, or other acquisition
-
42,500 Added 15.72%
227,935 Ordinary Shares
IJH

Iqbal J Hussain

General Counsel
Cheshire, X0

Track Institutional and Insider Activities on CNTA

Follow Centessa Pharmaceuticals plc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CNTA shares.

Notify only if

Insider Trading

Get notified when an Centessa Pharmaceuticals PLC insider buys or sells CNTA shares.

Notify only if

News

Receive news related to Centessa Pharmaceuticals plc

Track Activities on CNTA